Clinical Trial Update: Long-term Safety Study of MP-513 in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 long-term safety study of MP-513 in patients with Type 2 Diabetes Mellitus has completed and posted results. The update summarizes extended safety fin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MP-513

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2015-08-28